Appointment Length

A postdoctoral position is a short-term, training position which should lead to a research career in academics, private industry, or government. Appointments are established for an initial period of one year, with the possibility of being re-appointed annually for an additional three years, not to exceed a total of four years. A four year time period for postdoctoral training has become the recommended length for most universities. A time-limited appointment protects the postdoc from an indefinite length of stay in a training position and is an adequate period for transition into full time positions with appropriate salaries and benefits.

In some cases, a faculty member may wish to extend an individual's postdoctoral appointment beyond the fourth year. If so, a written request to the Associate Dean of the Office of Postdoctoral Education should be made before the end of the postdoc's fourth year. Requests for a fifth year must include a mutually agreed upon and detailed career development plan for the postdoc signed by both the mentor and the postdoc. In all cases, appointment as a postdoctoral scholar at UAB is limited to a period not to exceed five years.

UAB News

  • Lisa Tamiris Becker will begin work Sept. 1 as the new director for the Abroms-Engel Institute for the Visual Arts.The University of Alabama at Birmingham College of Arts and Sciences has announced Lisa Tamiris Becker as the new director for the Abroms-Engel Institute for the Visual Arts. She will begin work at UAB on Sept. 1. Becker previously directed the art museums at the University of New Mexico and the University of Colorado, Boulder. In her...

  • If successful, the PRESERVE-1 trial could be a significant clinical breakthrough in the treatment of the condition by prolonging pregnancy and improving outcomes. The University of Alabama at Birmingham Department of Obstetrics and Gynecology has enrolled the first patient in the United States in a Phase III clinical trial for a drug to treat preeclampsia in pregnant women that, if successful, would be a significant clinical breakthrough for reducing pre-term births and infant mortality. ATryn®, or antithrombin...

UAB Research News

  • New drugs to slow or even prevent Parkinson’s could be in human studies as early as 2015.Written by Matt Windsor An enzyme closely associated with genetic forms of Parkinson’s disease appears to play a larger role in its progression than previously thought, say investigators at the University of Alabama at Birmingham. The new research offers encouraging evidence that drugs to block this enzyme, known as leucine-rich repeat kinase 2 or LRRK2, could slow — or even...

  • UAB School of Nursing's federally funded study shows both the patient and caregiver benefit from early palliative care.The earlier a specific phone-based, palliative care support program can be introduced to caregivers, the better they will be able to cope with the caregiving experience, according to research conducted by University of Alabama at Birmingham School of Nursing investigators. The patient outcomes from the study, known as ENABLE III, were presented June 3 at the American Society of...